Erythromycin Oxime (CAS 13127-18-9)
QUICK LINKS
Erythromycin A Oxime (Roxithromycin) functions as a protein synthesis inhibitor by binding to the 50S ribosomal subunit of bacteria. This binding prevents the translocation of tRNA, thereby inhibiting the synthesis of proteins essential for bacterial growth. The chemical′s mode of action involves interfering with the peptide transferase activity of the ribosome, leading to the inhibition of protein synthesis. This disruption ultimately results in the bacteriostatic effect of Erythromycin A Oxime (Roxithromycin) on susceptible bacteria. The chemical′s interaction with the ribosomal subunit prevents the formation of functional 70S initiation complexes, further contributing to its inhibitory effect on bacterial protein synthesis. Erythromycin A Oxime (Roxithromycin) plays a role in disrupting bacterial protein synthesis through its specific binding to the 50S ribosomal subunit, ultimately inhibiting bacterial growth.
Erythromycin Oxime (CAS 13127-18-9) References
- A new convenient transformation of erythromycin A into clarithromycin. | Allevi, P., et al. 1999. Bioorg Med Chem. 7: 2749-52. PMID: 10658579
- Applications of liquid chromatography-tandem mass spectrometry in drug and biomedical analyses. | Zhong, D., et al. 2001. Clin Chim Acta. 313: 147-50. PMID: 11694253
- pH-dependent geometric isomerization of roxithromycin in simulated gastrointestinal fluids and in rats. | Zhang, S., et al. 2004. J Pharm Sci. 93: 1300-9. PMID: 15067706
- Impact of pharmaceutical dosage forms on the pharmacokinetics of roxithromycin in healthy human volunteers. | Sun, J., et al. 2005. J Antimicrob Chemother. 55: 796-9. PMID: 15761061
- High-throughput method for macrolides and lincosamides antibiotics residues analysis in milk and muscle using a simple liquid-liquid extraction technique and liquid chromatography-electrospray-tandem mass spectrometry analysis (LC-MS/MS). | Jank, L., et al. 2015. Talanta. 144: 686-95. PMID: 26452878
- Distribution of Animal Drugs between Skim Milk and Milk Fat Fractions in Spiked Whole Milk: Understanding the Potential Impact on Commercial Milk Products. | Hakk, H., et al. 2016. J Agric Food Chem. 64: 326-35. PMID: 26652058
- Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo. | Čipčić Paljetak, H., et al. 2016. Antimicrob Agents Chemother. 60: 5337-48. PMID: 27353268
- From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials. | Jelić, D. and Antolović, R. 2016. Antibiotics (Basel). 5: PMID: 27598215
- Recent Advances in the Development of Macrolide Antibiotics as Antimicrobial Agents. | Qin, Y. and Ma, S. 2020. Mini Rev Med Chem. 20: 601-625. PMID: 31868146
- Analysis and occurrence of macrolide residues in stream sediments and underlying alluvial aquifer downstream from a pharmaceutical plant. | Senta, I., et al. 2021. Environ Pollut. 273: 116433. PMID: 33486242
- Erythromycin VI: kinetics of acid-catalyzed hydrolysis of erythromycin oxime and erythromycylamine. | Lazarevski, T., et al. 1978. J Pharm Sci. 67: 1031-3. PMID: 660496
- Erythromycin series. V. Quantitative analysis of cladinose and methylcladinoside by densitometry of thin-layer chromatograms. | Lazarevski, T., et al. 1977. J Chromatogr. 132: 309-13. PMID: 833239
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Erythromycin Oxime, 10 mg | sc-207633 | 10 mg | $92.00 | |||
Erythromycin Oxime, 100 mg | sc-207633A | 100 mg | $194.00 | |||
Erythromycin Oxime, 250 mg | sc-207633B | 250 mg | $326.00 | |||
Erythromycin Oxime, 1 g | sc-207633C | 1 g | $663.00 |